Else Nutrition cheers signing of FDA funding package

Ms. Hamutal Yitzhak reports ELSE NUTRITION ANNOUNCES MAJOR BREAKTHROUGH: PRESIDENT TRUMP SIGNS PIVOTAL FDA FUNDING PACKAGE THAT INCLUDES CONGRESSIONAL DIRECTIVE STREAMLINING REGULATORY PATHWAY FOR NON-DAIRY, NON-SOY PLANT-BASED INFANT FORMULA Else Nutrition Holdings Inc. has recognized the bicameral, bipartisan passage of the U.S. government budget for fiscal year 2026 that officially ended the U.S. government shutdown, marking a major milestone for the company. The budget signed into law by President Donald Trump includes report language bolstering operation stork speed and also directs the Food and Drug Administration to streamline regulatory pathways for new infant formulas, specifically including plant-based, non-soy, non-dairy formula solutions, a report provision secured directly through the company's government affairs initiatives. This legislative milestone is incorporated into the Congressional Directives of the passed budget through H. Rept. 119-172 and is expected to streamline and accelerate regulatory pathways and guidance at the FDA for plant-based, non-soy, non-dairy formula. Else expects that, as FDA employees return to work now that the U.S. government shutdown has ended, this guidance process may begin in earnest, marking a pivotal moment for American families seeking inclusive and safe nutritional alternatives. "For too many parents, the absence of truly inclusive formula options has been a daily worry," said Hamutal Yitzhak, co-founder and chief executive officer of Else Nutrition. "Congress has sent a clear directive: U.S. regulatory policy will soon catch up to the reality that babies' nutritional needs and families' values are evolving. We congratulate Congress on this momentum, and we stand ready to deliver on the promise. "Furthermore, we are especially grateful to President Trump and secretary Robert F. Kennedy for their leadership, bringing new infant formulas to the American infants who need it most through operation stork speed -- a strong initiative that, in part through this legislative development, may soon include plant-based, non-soy, non-dairy formulas." Key highlights: The report advanced by the U.S. House of Representatives includes language directing the FDA to establish clear approval pathways and provide formal regulatory guidance for plant-based, non-soy, non-dairy infant formulas, recognizing families with allergies, intolerances, sensitivities or lifestyle/ethical preferences. With the government shutdown officially concluded, Else Nutrition is positioned to accelerate engagement with federal regulators to scale U.S. access and support families who have long waited for alternatives. Else's product pipeline, which includes its already-launched toddler nutrition line made from whole foods (almonds, buckwheat and tapioca) and ingredients with clean-label appeal, is now strategically suited for the U.S. infant formula market when regulatory conditions allow. This moment is not only a major business milestone for Else that demonstrated its success in navigating complex U.S. government regulatory dynamics, but a significant public health and consumer choice inflection point: expanding nutritional equity for infants regardless of dietary, allergy or lifestyle constraints. Families across America face a narrowing field of formula choices, often limited to dairy- or soy-based products. For those whose infants cannot use these choices, or for families seeking plant-based, allergen-aware options, innovation has lagged. The U.S. government's action, now signed into law, signals a regulatory paradigm shift that may be coming in favour of innovation, choice and accessibility. Ms. Yitzhak added: "Else has long maintained that every child deserves safe, effective and nutritionally complete baby formula options that reflect today's values and challenges. With this legislative accomplishment, we are entering the final phase of the U.S. policy transformation that will enable us to bring those options to market more rapidly and responsibly." Else Nutrition will continue direct engagement with the FDA and federal representatives to ensure that implementation of the legislation fosters science-backed, verified product pathways. The company remains committed to rigorous product standards, transparency and the needs of families who cannot afford to wait. About Else Nutrition Holdings Inc. Else Nutrition is a food and nutrition company in the international expansion stage focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its plant-based complete nutrition for toddlers, made of whole foods, almonds, buckwheat and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth. We seek Safe Harbor.